Hutch News

Hutch News

Stories tagged 'checkpoint inhibitors'

Dr. Cameron Howard Lee named 2019 Helen Hay Whitney Fellow

Biggins Lab postdoc will look at relationship between protein production and key cell-cycle checkpoint

Nov. 26, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Cameron Howard Lee, a postdoctoral fellow in the laboratory of Dr. Sue Biggins at Fred Hutch, has been named a 2019 Helen Hay Whitney fellow by the Helen Hay Whitney Foundation.

View story >


Revealing a new way that cancer can evade immunotherapy — and, maybe, how to stop it

How a new technology solved a mystery and honors one man’s legacy

Sept. 24, 2018 | by Susan Keown / Fred Hutch News Service

Before his aggressive cancer took his life, he donated his tissue samples to research. Now scientists think that new insights from his cells could save lives.

View story >


Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma

‘Incredibly big change’ in treatment of deadly skin cancer, new data show

June 4, 2018 | by Susan Keown / Fred Hutch News Service

Immunotherapy drugs have transformed the treatment of a deadly skin cancer, Merkel cell carcinoma. New trial results show these drugs help many patients survive much longer than would otherwise be possible.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.